The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Global real-world patients characteristics, treatment patterns, and impact of BCG shortage in patients with high-risk non-muscle invasive bladder cancer.
 
Jens Bedke
Consulting or Advisory Role - Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Eisai; Ipsen; Janssen; Merck KGaA; MSD Oncology; Pfizer; Roche
Speakers' Bureau - Apogepha; Astellas Pharma; Bristol-Myers Squibb; Ipsen; Merck KGaA; MSD Oncology; Pfizer
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Ipsen (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); SeaGen (Inst)
Travel, Accommodations, Expenses - Ipsen (Inst); Merck KGaA (Inst)
 
Anthony Eccleston
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Julia Brinkmann
Employment - Guerbet (I); Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jane Chang
Employment - Pfizer
Stock and Other Ownership Interests - Bayer; BMS; Pfizer; Viatris
Research Funding - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Abin Koshy
Employment - Pfizer
 
Neil Milloy
No Relationships to Disclose
 
Laure Manuel
No Relationships to Disclose
 
Jacob Skilling
No Relationships to Disclose
 
Emilia Biondi
No Relationships to Disclose
 
Elliott Brown
No Relationships to Disclose
 
Gary Steinberg
Stock and Other Ownership Interests - CG Oncology; enGene; Epivax Therapeutics
Honoraria - Aduro Biotech; AstraZeneca; Bristol-Myers Squibb; CG Oncology; enGene; Epivax Oncology; fergene; Ferring; Fidia Farmaceutici S. p. A.; FKD Therapies; Janssen Oncology; MDxHealth; Merck; Pfizer; Photocure; Roche/Genentech; Seagen; Sesen Bio; Urogen pharma
Consulting or Advisory Role - Asieris Pharmaceuticals; AstraZeneca; Aura Biosciences; Boston Scientific; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; Imvax; MDxHealth; Merck; NanOlogy; Natera; Nonagen Bioscience; photocure; Roche/Genentech; Taris BioMedical; Verity Pharmaceuticals
 
Oscar Rodriguez Faba
No Relationships to Disclose
 
Yohann Loriot
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Janssen; Loxo/Lilly; Merck KGaA; MSD Oncology; MSD Oncology (Inst); Pfizer (Inst); Pfizer/EMD Serono; Roche; Roche (Inst); Seagen; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen
 
Paolo Gontero
Honoraria - Ferring; Janssen; Photocure
Speakers' Bureau - Medac
Research Funding - Astellas Pharma; Ferring; Ipsen; Janssen
 
Yair Lotan
Stock and Other Ownership Interests - C2i Genomics; CAPS Medical; Nanorobotics; Phinomics; Vessi Medical
Consulting or Advisory Role - Abbvie; Ambu; AstraZeneca; Aura Biosciences; Bristol-Myers Squibb; C2i Genomics; CAPS Medical; Cleveland Diagnostics; Convergent Genomics; FerGene; Ferring research; Hitachi; Merck; Nanorobotics; Nonagen; Nucleix; pacific edge; Pfizer; Photocure; Seagen; Stimit; Uroessentials; UroGen pharma; Valar Labs; Verity Pharmaceuticals; Vessi Medical; Virtuoso Surgical; xCures
Research Funding - C2i Genomics; Cepheid; enGene; FKD Therapies; GenomeDx; Janssen; MDxHealth; pacific edge; Seagen; Vaxiion